Yeah, I think you're right. Sanofi didn't partner but suggested to their competitor it would be a good fit for them and RB should go steal Sanofi's customers. A back door deal to lose market share makes perfect sense.
RAP Price at posting:
17.5¢ Sentiment: Buy Disclosure: Held